Defence Therapeutics (XCNQ:DTC) Scaled Net Operating Assets : -0.71 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Defence Therapeutics's operating assets for the quarter that ended in Dec. 2023 was C$0.32 Mil. Defence Therapeutics's operating liabilities for the quarter that ended in Dec. 2023 was C$1.45 Mil. Defence Therapeutics's Total Assets for the quarter that ended in Sep. 2023 was C$1.59 Mil. Therefore, Defence Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was -0.71.

Defence Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Defence Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Scaled Net Operating Assets Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Scaled Net Operating Assets

0.02

-0.16

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial										-1.48	-1.80	0.22	-0.05	-0.71

Competitive Comparison of Defence Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Defence Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Scaled Net Operating Assets falls into.

Defence Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Defence Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2022 )
=	(Operating Assets (A: Jun. 2022 )	-	Operating Liabilities (A: Jun. 2022 ))	/	Total Assets (A: Jun. 2021 )
=	(0.213	-	1.107)	/	5.609
=	-0.16

where

	Operating Assets		(A: Jun. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.72	-	0.507
=	0.213

	Operating Liabilities		(A: Jun. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.107	-	0	-	0
=	1.107

Defence Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Sep. 2023 )
=	(0.318	-	1.449)	/	1.588
=	-0.71

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.669	-	0.351
=	0.318

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.964	-	0.023	-	1.492
=	1.449

Defence Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director